Back
ResMed, Inc. 10K Form
Sell
50
RMD
ResMed, Inc.
Last Price:
$251.51
Seasonality Move:
5.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-27 | 10Q | RMD/ResMed, Inc. Quarterly |
| 2023-04-28 | 10Q | RMD/ResMed, Inc. Quarterly |
| 2023-01-27 | 10Q | RMD/ResMed, Inc. Quarterly |
| 2022-10-28 | 10Q | RMD/ResMed, Inc. Quarterly |
| 2022-04-29 | 10Q | RMD/ResMed, Inc. Quarterly |
| 2022-01-28 | 10Q | RMD/ResMed, Inc. Quarterly |
Receive RMD News And Ratings
See the #1 stock for the next 7 days that we like better than RMD
RMD Financial Statistics
Sales & Book Value
| Annual Sales: | $5.1B |
|---|---|
| Cash Flow: | $411.5M |
| Price / Cash Flow: | 21.06 |
| Annual Sales: | $41.94 |
| Price / Book: | 6 |
Profitability
| EPS (TTM): | 9.77130 |
|---|---|
| Net Income (TTM): | $1.4B |
| Gross Margin: | $3B |
| Return on Equity: | 25.6% |
| Return on Assets: | 18.72% |
ResMed, Inc. Earnings Forecast
Key ResMed, Inc. Financial Ratios
-
The Gross Profit Margin over the past 33 years for RMD is 58.48%.
-
The Selling, General & Administrative Expenses for RMD have been equal to 19.26% of Gross Profit Margin.
-
The Research & Development expenses have been 6.44% of Revenue.
-
The Interest Expense is 0.90% of Operating Income.
-
The Net Earning history of RMD is 27.22% of Total Revenues.
-
Per Share Earnings over the last 33 years have been positive in 25 years.
ResMed, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | RMD |
| CUSIP: | 761152 |
| Website: | resmed.com |
Debt
| Debt-to-Equity Ratio: | 0.14 |
|---|---|
| Current Ratio: | 2.89 |
| Quick Ratio: | 1.89 |
Price-to-Earnings
| Trailing P/E Ratio: | 26.45 |
|---|---|
| Forward P/E Ratio: | 20.93 |
RMD Technical Analysis vs Fundamental Analysis
Sell
50
ResMed, Inc. (RMD)
is a Sell
Is ResMed, Inc. a Buy or a Sell?
-
ResMed, Inc. stock is rated a SellThe current ResMed, Inc. [RMD] share price is $251.51. The Score for RMD is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.